期刊文献+

IgA肾病伴高血压患者临床病理学特点 被引量:3

下载PDF
导出
摘要 目的探讨Ig A肾病伴高血压患者的检出率,并探讨其临床病理特点。方法选择在本院行肾穿刺活检确诊为Ig A肾病的190例患者的临床和病理资料,依据是否合并有高血压,分为高血压组和血压正常组,对比分析两组的临床病理特点。结果 190例Ig A肾病患者中,伴高血压的有109例,检出率是57.39%。与血压正常组相比,高血压组在24小时尿蛋白定量、血肌酐、血尿酸、甘油三酯、球性硬化、节段硬化、小管萎缩、炎细胞浸润、间质纤维化等方面的均较血压正常组严重,两组比较有统计学意义。结论 Ig A肾病伴高血压的检出率较高,与血压正常组相比,其临床、病理均相对较重,故加强血压的控制,有利于该病的综合防治。
出处 《心脑血管病防治》 2015年第2期124-126,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献5

  • 1梁孟君,欧姆,陈绪敏,张望,陈崴,杨琼琼,毛海萍,余学清.IgA肾病患者高尿酸血症患病率及其相关危险因素分析[J].中华肾脏病杂志,2013,29(5):326-332. 被引量:27
  • 2Le W, Hang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nepat)pathy: results from a cohort of 1155 eases in a Chinese adult population[J] . Nephrol Dial Transplant, 2012,27 (4): 1479- 1485.
  • 3Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet,2012,37(9) :815 - 822.
  • 4王梅,王玉.高血压性肾损害.见:王海燕.肾脏病学.第3版.北京:人民卫生出版社,2008.1662-1668.
  • 5Philip Kam, Tao Li, Kelvin Kai, et al. Prognostic indicators of IgA nephropathy in the Chinese: clinical and pathological perspectives [J]. Nephtvlogy Dialysis Transplantation , 2002,17 ( 1 ) : 64 - 69.

二级参考文献15

  • 1Donadio JV, Grande JP. IgA nephropathy. N Engl J Med,2002,347: 738-748.
  • 2Le W, Liang S, Hu Y, et al. Long - term renal survival andrelated risk factors in patients with IgA nephropathy: resultsfrom a cohort of 1155 cases in a Chinese adult population.Nephrol Dial Transplant, 2012, 27: 1479-1485.
  • 3Kang DH, Chen W. Uric acid and chronic kidney disease: newunderstanding of an old problem. Semin Nephrol, 2011,31:447-452.
  • 4Syrjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemiaand hyperuricaemia are risk factors for progression of IgAnephropathy. Nephrol Dial Transplant, 2000, 15: 34-42.
  • 5Ohno I, Hosoya T, Gomi H, et al. Serum uric acid and renalprognosis in patients with IgA nephropathy. Nephron, 2001,87: 333-339.
  • 6Shi Y, Chen W, Jalal D, et al. Clinical outcome ofhyperuricemia in IgA nephropathy: a retrospective cohort studyand randomized controlled trial. Kidney Blood Press Res,2012,35: 153-160.
  • 7Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascularrisk. N Engl J Med, 2008, 359: 1811-1121.
  • 8Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidneydisease in China: a cross - sectional survey. Lancet, 2012,379:815-822.
  • 9National Kidney Foundation. K/DOQI clinical practiceguidelines for chronic kidney disease: evaluation,classification, and stratification. Am J Kidney Dis, 2002, 39:S1-S266.
  • 10Chen W, Wang H, Dong X, et al. Prevalence and risk factorsassociated with chronic kidney disease in an adult populationfrom southern China. Nephrol Dial Transplant, 2009, 24: 1205-1212.

共引文献27

同被引文献29

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部